Search Results - Neal Bhatia

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Biomarkers in Cutaneous Keratinocyte Carcinomas by Erica Montano, Neal Bhatia, Jelena Ostojić

    Published in Dermatology and Therapy (2024-07-01)
    Get full text
    Article


  2. 2

    Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis by Neal Bhatia, Jayme Heim, Brad Schenkel, J. Gabriel Vasquez

    Published in Journal of Dermatological Treatment (2023-12-01)
    Get full text
    Article


  3. 3

    Correction: Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROS... by Neal Bhatia, Charles W. Lynde, Luz Fonacier, Liyang Shao, Kwinten Bosman, Andrew Korotzer

    Published in Dermatology and Therapy (2025-07-01)
    Get full text
    Article


  4. 4

    Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry by Neal Bhatia, Charles W. Lynde, Luz Fonacier, Liyang Shao, Kwinten Bosman, Andrew Korotzer

    Published in Dermatology and Therapy (2025-04-01)
    Get full text
    Article


  5. 5

    Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting by Neal Bhatia, Jayme Heim, J. Gabriel Vasquez, Tina Bhutani, Brad Schenkel, Ranga Gogineni, John Koo

    Published in Journal of Dermatological Treatment (2024-12-01)
    Get full text
    Article


  6. 6

    Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis by Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J. Gabriel Vasquez

    Published in Dermatology and Therapy (2024-04-01)
    Get full text
    Article


  7. 7

    Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials by Zoe D. Draelos, Emil A. Tanghetti, Leon H. Kircik, Neal Bhatia, Joshua A. Zeichner, Jeffrey L. Sugarman, Linda Stein Gold

    Published in Journal of Dermatological Treatment (2023-12-01)
    Get full text
    Article


  8. 8

    Long Term Follow-Up of Stereotactic Body Radiation Therapy for Refractory Ventricular Tachycardia in Advanced Heart Failure Patients by John Wight, Thomas Bigham, Arielle Schwartz, Arslan T. Zahid, Neal Bhatia, Soroosh Kiani, Anand Shah, Stacy Westerman, Kristin Higgins, Michael S. Lloyd

    Published in Frontiers in Cardiovascular Medicine (2022-04-01)
    Get full text
    Article


  9. 9

    A Review of the Diagnostic and Therapeutic Gaps in Rosacea Management: Consensus Opinion by James Del Rosso, Hilary Baldwin, Neal Bhatia, Rajeev Chavda, Jean Phillipe York, Julie Harper, Firas George Hougeir, J. Mark Jackson, Omar Noor, David A. Rodriguez, Todd Schlesinger, Jonathan Weiss

    Published in Dermatology and Therapy (2024-01-01)
    Get full text
    Article


  10. 10

    Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 studyCapsule Summary by Neal Bhatia, MD, Edward Lain, MD, Abel Jarell, MD, Janet DuBois, MD, Maria Luisa Tamarit, MD, Meritxell Falques, MSc, Vera Kiyasova, MD, PhD, Laura Padullés, PhD, Raquel Otero, PhD, Andrew Blauvelt, MD, MBA

    Published in JAAD International (2024-12-01)
    Get full text
    Article


  11. 11

    Expert consensus-based recommendations on the use of photodynamic therapy in actinic keratosis patientsCapsule Summary by Vishal A. Patel, MD, Sarah T. Arron, MD, Brian Berman, MD, PhD, M. Shane Chapman, MD, MBA, Anokhi Jambusaria-Pahlajani, MD, George Martin, MD, Anthony M. Rossi, MD, Todd Schlesinger, MD, Nathalie C. Zeitouni, MDCM, Neal Bhatia, MD

    Published in JAAD International (2025-06-01)
    Get full text
    Article


  12. 12

    Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis by Leon H. Kircik, Linda Stein Gold, Michael Gold, Jonathan S. Weiss, Julie C. Harper, James Q. Del Rosso, Christopher G. Bunick, Neal Bhatia, Emil A. Tanghetti, Lawrence F. Eichenfield, Hilary Baldwin, Zoe D. Draelos, Valerie D. Callender, George Han, Melinda J. Gooderham, Neil Sadick, Mary P. Lupo, Edward (Ted) Lain, William Philip Werschler

    Published in Dermatology and Therapy (2024-05-01)
    Get full text
    Article


  13. 13

    Integrating wearables into the modern electrophysiology practice: A proposed framework for the use of wearables and creation of a remote digital clinic by Krishna Pundi, MD, Jason G. Andrade, MD, FHRS, Neal Bhatia, MD, Thomas Deneke, MD, PhD, FHRS, Hamid Ghanbari, MD, Matthew Kalscheur, MD, Peem Lorvidhaya, MD, FHRS, Jennifer N. Avari Silva, MD, FHRS, CEPS-P, Amit J. Thosani, MD, FHRS, Michael A. Rosenberg, MD, FHRS, Gerilynn M. Schott, MSN, ACNP, Amy G. Tucker, MSN, RN, FHRS, CCDS, Niraj Varma, MD, PhD, Omair Yousuf, MD, Peter A. Noseworthy, MD, MBA, FHRS

    Published in Heart Rhythm O2 (2025-09-01)
    Get full text
    Article


Search Tools: